Qnovia, Inc. announced its CEO is speaking publicly to FDA and NIH at the joint agency public meeting on Advancing Smoking Cessation today at FDA's White Oak Campus. Qnovia is a pharmaceutical company ...

CStone Pharmaceuticals (HK:2616) has released an update. CStone Pharmaceuticals has announced the publication of a patent for its innovative ...

In the wake of Pfizer’s voluntary market withdrawal of the popular sickle cell disease therapy, BioSpace looks at five investigational drugs currently making their way through the pipeline.

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novavax, Inc. (“Novavax” or ...

Gilead Sciences (GILD) and Merck (MRK) announced new results from a Phase 2 clinical study evaluating the investigational combination of ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Kineta has completed enrollment in the monotherapy cohorts of the Phase 1 VISTA-101 clinical trial. The ongoing Phase 1 study is now enrolling patients into cohorts evaluating KVA12123 in combination ...

HERZLIA, Israel, October 21, 2024--(BUSINESS WIRE)--Endospan, a pioneer in endovascular solutions for the Aortic Arch, today ...

Oregon decriminalized hard drugs in 2021 and recriminalized them last month. A new analysis shows the laws likely had little ...

The Wegovy makers’s once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in ...

ASX-listed Radiopharm Theranostics has partnered with US-based BAMF Health for a phase 2b trial in the US to test its ...